NotizieBenzingaBristol Myers Squibb Announces Topline Results From Unit RayzeBio's Planned Interim Analysis Of ACTION-1 Trial; RYZ101 Study Met Primary Endpoint With Statistically Significant And Clinically Meaningful Improvement In Progression-Free Survival By... Bristol Myers Squibb Announces Topline Results From Unit RayzeBio's Planned Interim Analysis Of ACTION-1 Trial; RYZ101 Study Met Primary Endpoint With Statistically Significant And Clinically Meaningful Improvement In Progression-Free Survival By... Benzinga 2026.10.12 11:03 (GMT+0) Apri Benzinga Altre notizie Newline by Fifth Third lancia carte Visa aziendali in oltre 40 paesi Cognizant amplia la partnership con Google Cloud con 18.000 ingegneri Alaska Airlines nomina Amaresh Siva come chief information officer Global-E Online in rialzo dopo l’upgrade di Morgan Stanley Le azioni di Match Group salgono dopo l’upgrade di Evercore ISI su Tinder World Copper acquisisce una proprietà di esplorazione aurifera in Nevada
